The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
18F-FDG PET/CT evaluation of tumor response to the implantation of RENCA macrobeads (RMB) in phase I and II clinical trials [INDBB 10091] in advanced, treatment-resistant metastatic colorectal cancer (mCRC).
 
Angelica Nazarian
No Relationships to Disclose
 
Sudipta Sureshbabu
No Relationships to Disclose
 
Zoe Padua Andrada
Stock and Other Ownership Interests - Abbott Laboratories; Aetna; Stryker
 
Joanne Thomas
No Relationships to Disclose
 
Anna Arreglado
No Relationships to Disclose
 
Nathaniel Berman
No Relationships to Disclose
 
David J. Wolf
No Relationships to Disclose
 
Lawrence S. Gazda
Research Funding - Metromedia Bio-Science (Inst)
Other Relationship - Metromedia Bio-Science
 
Thomas J. Fahey
No Relationships to Disclose
 
Allyson J. Ocean
Speakers' Bureau - Genentech; Ipsen; Prostrakan
 
Barry H. Smith
Research Funding - Metromedia Bio-Science (Inst)
Other Relationship - Metromedia Bio-Science